Join to access to all OVN content. Join for Free
How to Transition from MSL to MSL Leader
MSL to leadership personal development for managers effective time management strategies career advancement tips mentorship significance

How to Transition from MSL to MSL Leader


Share This Article


Summary

In this episode, Kathy Gann joins to discuss the transition from an MSL role to leadership positions. Kathy delves into personal development, goal setting, and the importance of lifelong learning and skill-building for aspiring managers. She shares insights on identifying the right time to step into management and the challenges that accompany such a transition. Kathy emphasizes effective time management, proactivity in career advancement, and the significance of mentorship. She also highlights strategies for gaining visibility through problem-solving and crafting a strategic leadership plan. The episode concludes with Kathy offering closing thoughts and acknowledgments.

Kathy Gann, Former Field MSL Director and MSL discusses how to transition from MSL to MSL Leader.

Kathy shares….

👉 How to position yourself for promotion

👉 What skills are mandatory and how to develop them

👉 How to prepare for a role in management

👉 The demands of being and MSL leader and what to expect

👉 The emotional side of being in charge of people

Click for Source
MSL to leadership, personal development for managers, effective time management strategies, career advancement tips, mentorship significance

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Promotability: Top 10 Tips for Landing Your Next Promotion
Partner Avatar MSL Talk: Tom Caravela, Bridget Rasmusson

Promotability: Top 10 Tips for Landing Your Next Promotion

Podcast
Diversity in Medical Affairs and the Power of Networking
Partner Avatar MSL Talk: Tom Caravela, Rachel Kennedy, Lashondra Taylor, Nirav Shah

Diversity in Medical Affairs and the Power of Networking

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Explore OVN